| MolName | (2Z)-2-[(5Z)-5-[[5-(4-morpholin-4-ylsulfonylphenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-3-oxo-3-pyrrolidin-1-ylpropanenitrile |
| MolecularFormula | C31H28N4O6S2 |
| Smiles | N#C/C(/C(N1CCCC1)=O)=C(\N(C1=O)c2ccccc2)/S/C1=C\c1ccc(-c(cc2)ccc2S(N2CCOCC2)(=O)=O)o1 |
| InChI | InChI=1S/C31H28N4O6S2/c32-21-26(29(36)33-14-4-5-15-33)31-35(23-6-2-1-3-7-23)30(37)28(42-31)20-24-10-13-27(41-24)22-8-11-25(12-9-22)43(38,39)34-16-18-40-19-17-34/h1-3,6-13,20H,4-5,14-19H2 |
| InChIK | JFYWSEDEOLVRJS-UHFFFAOYSA-N |
| TotalMolweight | 616.717 |
| Molweight | 616.717 |
| MonoisotopicMass | 616.145026 |
| CLogP | 4.045 |
| CLogS | -5.796 |
| H Acceptors | 10 |
| TotalSurfaceArea | 443.86 |
| Relative PSA | 0.27141 |
| PolarSurfaceArea | 157.84 |
| Druglikeness | 3.0491 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.48837 |
| Fragments | 1 |
| Non HAtoms | 43 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 5 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 11 |
| Symmetricatoms | 9 |
| Amides | 3 |
| StereoCon |
Click to Load Molecule:
1 - (2Z)-2-[(5Z)-5-[[5-(4-morpholin-4-ylsulfonylphenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-3-oxo-3-pyrrolidin-1-ylpropanenitrile | 2 - (2Z)-2-[(5Z)-5-[[5-(4-morpholin-4-ylsulfonylphenyl)furan-2-yl]methylidene]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-3-oxo-3-pyrrolidin-1-ylpropanenitrile